Acting so, at micromolar concentrations, physiological ascorbate, a fully reduced form of vitamin C (VC), can reduce harmful ROS
One area that has attracted academic discussion, press coverage, and significant biotechnology/pharma R&D investment is concern about undesirable, collateral skeletal muscle mass (SMM) loss, and presumably by extension, loss of strength and function in people taking GLP-1 medications
The organization also questioned whether the decision to end the shortages was too soon, as it noted hundreds of thousands of patients will have to transition to the brand-name medications in just a few months
Think of it like layering skincare, but for your insides
Weight loss plateaus are normal during semaglutide treatment